Speaker illustration

Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)

Member of:

European Society of Cardiology

Panel discussion and Q&A

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session: Navigating therapeutic approaches in HCM: unravelling recent evidence

Thumbnail

Precision medicine and focused recommendations in HCM guidelines

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session: Navigating therapeutic approaches in HCM: unravelling recent evidence

Thumbnail

Cardiac physiology and pathophysiology of HCM: including peak oxygen uptake (pVO2)

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session: Navigating therapeutic approaches in HCM: unravelling recent evidence

Thumbnail

Challenge 3 - disease modifying treatment for ATTR-CM

Event: Heart Failure 2024

Topic: Cardiac Amyloidosis

Session: Challenges in ATTR Amyloidosis: an expert debate

Thumbnail

REDWOOD-HCM-Cohort 4: Aficamten in non-obstructive HCM

Event: Heart Failure 2023

Topic: Hypertrophic Cardiomyopathy

Session: Late breaking clinical trials: chronic HF and cardiomyopathies

Thumbnail

REDWOOD-HCM OLE: aficamten in HCM

Event: Heart Failure 2022

Topic: Hypertrophic Cardiomyopathy

Session: Registries and Trial updates II

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb